Compare Centene Corp (CNC) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs Tesla, Inc. — how do they compare? Centene Corp trades at $66.8 (market cap $33.93B), while Tesla, Inc. trades at $397.69 (market cap $1.49T). The key difference: Tesla, Inc. is far larger — about 43.9× Centene Corp's market cap, and Centene Corp is trading nearer its 52-week high, Tesla, Inc. nearer its low. Which is the better fit depends on your goals.
| CNC | TSLA | |
|---|---|---|
Market Cap | $33.93B | $1.49T |
Sector | Health | Consumer Cyclical |
52-Week High | $68.72 | $489.88 |
52-Week Low | $25.21 | $302.63 |
Enterprise Value | $26.56B | $1.46T |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.
Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.
Tesla (TSLA) trades at $394.76, down 3.18% on the day, amid a bearish technical signal and mixed earnings history. The stock shows elevated valuation ratios with a P/E of 363.47 and P/S of 14.3, while profitability metrics like net income margin have softened to 3.95%. Recent news highlights regulatory approval for its driver-assistance software in Europe and a strategic pivot toward robotics and AI.
Tesla faces near-term headwinds from slowing auto demand and intense competition, but long-term growth hinges on autonomous driving and energy segments. Analyst consensus is mixed with a $409.26 price target, suggesting modest upside. Key risks include execution on AI initiatives and macroeconomic pressures on consumer spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
